The toy is interactive, letting kids check his sugar levels with a simple squeeze of any of his fingers. If glucose is too high, a toy insulin pen along with the interactive touchscreen on the bear’s chest can be used to correct it. Moreover, Jerry can be fed various foods that come in the form […]
Global Data estimates that the blood glucose monitoring business will reach 12.2 billion dollars by 2017. The new UniStrip1 is poised to capitalize on this market by offering low cost alternative test strip to use with some LifeScan monitors.
Throughout July, we’re featuring excerpts from Ginger Vieira’s new book, Dealing with Diabetes Burnout. In this second of four excerpts being featured, Vieira argues small daily victories in daily diabetes care are better than shooting for being a perfect person with diabetes.
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) suggests that consuming whey protein before a regular breakfast reduces the blood sugar spikes seen after meals and also improves the body’s insulin response.
Afrezza is a rapid-acting inhaled insulin to be administered prior to meals or within 20 minutes of starting a meal. It is not a substitute for long-acting insulin and must be used in combination with long-acting insulin in patients with type 1 diabetes. It is not recommended for the treatment of diabetic ketoacidosis or in […]
A new inhaled insulin is finally approved! When is predictive low glucose suspend coming? Plus, the launch of a new meter and more!
Heather reviews TruePlus glucose products, a line of products from Nipro Diagnostics that includes a flavorful variety of glucose tabs, gel, and liquid “shots”.
Researchers at Brown University may have developed a new sensor that would allow the sampling of saliva for glucose testing. The sensor relies on plasmonic interferometry, a light-based way of detecting chemical compounds, and a dual-enzyme assay that works as a dye, to mark glucose.
A recently completed study that compared two types of insulin for treating inadequately controlled type 2 patients showed that insulin degludec/insulin aspart produced fewer instances of hypoglycemia than biphasic insulin aspart 30.
For patients with type 2 diabetes – especially those over age 50 – the negative impact of side effects like weight gain and burdens like frequent insulin shots trumps the benefits of drugs, says a new study by the University of Michigan Health System, the VA Ann Arbor Healthcare System, and University College London.
People with type 1 or 2 diabetes now have a new means of getting their medication, with the U.S. Food and Drug Administration’s approval on Friday of the first inhaled medicine for the blood sugar disease.
Unveiled at the American Diabetes Association’s 74th Scientific Sessions earlier this month, their new Surveillance Error Grid (SEG) has the potential to give doctors and people with diabetes the ability to keep track of how these meters perform in the years after initial review, as they continue to be sold on the market.
In some estimates, it’s believed that as many as 2.6% of people with diabetes experience some form of allergic reaction to various forms of insulin. Such cases are uncommon, but they have been documented. Reactions range from frustrating to life-threatening.
Two famous studies showed that tight control of glucose did not cause a statistically significant reduction in heart attacks or early death. But roughly 20 years after the studies ended, tight control subjects are living longer and healthier than those who were in the comparison groups. What is going on?
Co-infusion of glucagon and glucagon-like peptide 1 (GLP-1) correlates with a reduction in appetite, and GLP-1 protects against glucagon-induced hyperglycemia in healthy volunteers, according to a study published online June 17 in Diabetes.
The experimental is going mainstream in Europe, as Medtronic announced it has gained approval from European regulators to sell the Duo, a connected insulin pump and continuous glucose monitoring system. From the way it’s described in Fierce Medical Devices, the Duo sounds a lot like the pump-CGM combo that some researchers are testing in their […]
Each year, more than 15,000 experts in the field of diabetes convene at the American Diabetes Association’s Scientific Sessions to hear the latest news in diabetes research, medical devices, and clinical practices. At Insulin Nation, we’ve summed up 7 additional big ideas at this year’s sessions.
The companies are seeking ways to integrate health sensors and apps into their wearable devices, including those to measure glucose levels in a non-invasive way.
Diabetes patients stand to benefit from two experimental insulin therapies that could eventually replace Sanofi’s global leader Lantus, according to results from large clinical trials
Peters and her co-authors described the new guidelines as filling a need in the medical community as type 1 diabetes is often grouped with type 2 diabetes in adults or considered only a pediatric disease where a fear of hypoglycemia previously mandated staged glycemic targets.